Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
July 13, 2000
Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter
F Tiberghien, T Kurome, K Takesako, et al.
International Journal of Cancer
|
October 31, 1998
Identification of gp100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells
I Kawashima, V Tsai, S Southwood, et al.
Molecular & General Genetics : MGG
|
April 2, 1999
An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activity
M Kuroda, T Hashida-Okado, R Yasumoto, et al.
Molecular & General Genetics : MGG
|
May 23, 1996
AUR1, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells
T Hashida-Okado, A Ogawa, M Endo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 1999
Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes
K Tahara, K Takesako, A Sette, et al.
International Journal of Cancer
|
February 6, 1999
A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes
T Fujie, K Tahara, F Tanaka, et al.
Cancer Research
|
February 2, 1999
Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells
I Kawashima, V Tsai, S Southwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Induction of antitumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2-restricted MAGE-3 peptide in vitro
T Fujie, F Tanaka, M Mori, et al.
Journal of the Neurological Sciences
|
February 1, 1993
Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis
Y Mimura, M Kuriyama, Y Tokimura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
T Nishiyama, M Tachibana, Y Horiguchi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
July 13, 2000
Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter
F Tiberghien, T Kurome, K Takesako, et al.
International Journal of Cancer
|
October 31, 1998
Identification of gp100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells
I Kawashima, V Tsai, S Southwood, et al.
Molecular & General Genetics : MGG
|
April 2, 1999
An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activity
M Kuroda, T Hashida-Okado, R Yasumoto, et al.
Molecular & General Genetics : MGG
|
May 23, 1996
AUR1, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells
T Hashida-Okado, A Ogawa, M Endo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 1999
Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes
K Tahara, K Takesako, A Sette, et al.
International Journal of Cancer
|
February 6, 1999
A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes
T Fujie, K Tahara, F Tanaka, et al.
Cancer Research
|
February 2, 1999
Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells
I Kawashima, V Tsai, S Southwood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Induction of antitumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2-restricted MAGE-3 peptide in vitro
T Fujie, F Tanaka, M Mori, et al.
Journal of the Neurological Sciences
|
February 1, 1993
Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis
Y Mimura, M Kuriyama, Y Tokimura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
T Nishiyama, M Tachibana, Y Horiguchi, et al.
Page
of 5